Posted by AGORACOM-JC
at 8:07 AM on Tuesday, December 18th, 2018
Tax loss selling season is upon us once again and you know what that means … George vs Allan Stock Picking Contest!! In this special episode, George and Allan give their Top 5 Tax Loss Selling Candidates (+ 1 Bonus Pick) that are most likely to provide a pop to their portfolios by January 30, 2019. There is a lot on the line in the wager between the two, with each providing completely different picks from the other and some great potential trades for viewers.
*NOTE – Due to a family emergency in February, Allan and I weren’t able to post our contest closing video with the results. However, the final results were as follows:
George + 40.2% (Winner)
Allan + 19.74%
Pretty damn good returns by both of us for 45 days!
Posted by AGORACOM-JC
at 6:19 PM on Monday, December 17th, 2018
Entered a commercial agreement with a Major Canadian Financial Institution to provide credit facilities that will give GLN access to an aggregate total of $11,250,000.
Included among the credit facilities is a $5,000,000 revolving line of credit to help support working capital as the company scales, and an acquisition line of credit to support company M&A strategies
VANCOUVER, Dec. 17, 2018 – Good Life Networks Inc. (“GLN“, or the “Company“) (TSXV: GOOD) (FSE: 4G5), a programmatic advertising technology company, today announced that it has entered a commercial agreement with a Major Canadian Financial Institution to provide credit facilities that will give GLN access to an aggregate total of $11,250,000. Included among the credit facilities is a $5,000,000 revolving line of credit to help support working capital as the company scales, and an acquisition line of credit to support company M&A strategies. Management plans to access funds from the acquisition line of credit to complete a recently announced acquisition.
“The credit facilities will help us meet our growth objectives while
maximizing shareholder value,” said GLN CEO Jesse Dylan. “We are
thrilled to be working with a Major Canadian Financial Institution now
and in the future as we continue to scale our business.”
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this
release.
The GLN Story GLN’s technology is the engine that
sits between advertisers and publishers. The GLN Platform is built for
cross device video advertising: Mobile, In-App, Desktop and CTV
(Connected Television). The Programmatic Video Marketing Platform is
powered by GLN’s Patent Pending proprietary machine learning technology
that targets and connects digital advertisers with consumers three times
faster than industry standards, with among the lowest fraud rates among
vendors without collecting PII (Personal Identifiable Information).
The Programmatic Video Technology Platform features integrations at
the server level with both Publishers and Advertisers. Our technology
quickly finds the most valuable advertisement for every consumer.
Publishers make more money through improved CPM (advertising fill rate)
combined with a more engaged consumer experience. Advertisers make more
money by reaching their target audience more effectively. GLN makes
money by retaining a percentage of the advertiser’s fee.
GLN is headquartered in Vancouver, Canada with offices
in the US and UK and trades on the TSX Venture Exchange under the stock
symbol “GOOD” and The Frankfurt Stock Exchange under the stock symbol
4G5.
Addressable Market: The total media ad spend worldwide will rise 7.4% to $628.63 billion
by this year, according to “Global Ad Spending: The eMarketer Forecast
for 2018.” By 2020, digital’s share of total advertising will near 50%.
Forward Looking Statements: Forward-looking
statements relate to future events or future performance and reflect the
expectations or beliefs regarding future events of management of GLN.
This information and these statements, referred to herein as
“forwardâ€looking statements”, are not historical facts, are made as of
the date of this news release and include without limitation, statements
regarding discussions of future plans, estimates and forecasts and
statements as to management’s expectations and intentions with respect
to the performance of the company. These statements generally can be
identified by use of forward-looking words such as “may”, “will”,
“expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue”
or the negative thereof or similar variations. These forwardâ€looking
statements involve numerous risks and uncertainties and actual results
might differ materially from results suggested in any forward-looking
statements. Important factors that may cause actual results to vary
include without limitation, risks relating to the digital advertising
industry and general economic conditions, success of acquisitions and
any growth strategies implemented utilizing the noted debt instrument.
In making the forwardâ€looking statements in this news release, the
Company has applied several material assumptions, including without
limitation that any acquisitions and corporate directives and
initiatives will be successfully completed in the time expected by
management and produce the desired results, generate the anticipated
revenue and expand GLN’s global reach per management’s expectations. GLN
does not assume any obligation to update the forward-looking
statements, or to update the reasons why actual results could differ
from those reflected in the forward looking-statements, other than as
required by applicable securities laws. Additional information
identifying risks and uncertainties is contained in GLN’s filings with
the Canadian securities regulators, which filings are available at www.sedar.com.
Posted by AGORACOM-JC
at 4:45 PM on Monday, December 17th, 2018
Announced today that it intends to complete a non-brokered private placement financing for gross proceeds up to $3,045,000, by issuing 5,250,000 Units at a price of $0.85 per Unit for which it has received conditional approval from the TSXV.
“The timing of this financing may seem a bit unusual given recent press releases,†said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “However, management decided to take advantage of this proposal given the opportunities before us, all of which we expect will become much clearer within the next 3 weeks.â€
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
MONTREAL, Dec. 17, 2018 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF), a TSX Venture 50® high-tech company, (the “Company”, the “Corporation†or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that it intends to complete a non-brokered private placement financing (the “Offering”) for gross proceeds up to $3,045,000, by issuing 5,250,000 Units at a price of $0.85 per Unit for which it has received conditional approval from the TSXV.
“The timing of this financing may seem a bit unusual given recent
press releases,†said Mr. P. Peter Pascali, President and CEO of
PyroGenesis. “However, management decided to take advantage of this
proposal given the opportunities before us, all of which we expect will
become much clearer within the next 3 weeks.â€
Each Unit will consist of one common share in the capital of the
Company and one full common share purchase warrant (“Unit Warrantâ€),
each full Unit Warrant entitling the holder to acquire one common share
of the Company at a price of $0.85 until December 18th, 2020.
The Corporation will pay a finder’s fee of 7% on a portion of the
proceeds of this Private Placement. The Corporation will not issue any
finder’s compensation warrants in connection with this Private
Placement.
The proceeds from the Private Placement will be used by the Corporation for general corporate purposes.
The Private Placement is subject to the final approval of the TSX
Venture Exchange (“TSXVâ€) as well as other customary closing conditions.
This news release does not constitute an offer to sell or a
solicitation of an offer to buy any of the securities in the United
States. The securities have not been and will not be registered under
the United States Securities of 1933, as amended, or any state
securities laws and may not be offered or sold within the United States,
unless an exemption from such registration is available.
PyroGenesis Canada Inc., a TSX Venture 50® high-tech company, is the
world leader in the design, development, manufacture and
commercialization of advanced plasma processes and products. We provide
engineering and manufacturing expertise, cutting-edge contract research,
as well as turnkey process equipment packages to the defense,
metallurgical, mining, advanced materials (including 3D printing), oil
& gas, and environmental industries. With a team of experienced
engineers, scientists and technicians working out of our Montreal office
and our 3,800 m2 manufacturing facility, PyroGenesis maintains its
competitive advantage by remaining at the forefront of technology
development and commercialization. Our core competencies allow
PyroGenesis to lead the way in providing innovative plasma torches,
plasma waste processes, high-temperature metallurgical processes, and
engineering services to the global marketplace. Our operations are ISO
9001:2015 certified, and have been since 1997. PyroGenesis is a
publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker
Symbol: PYR) and on the OTCQB Marketplace. For more information, please
visit www.pyrogenesis.com
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward- looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Corporation’s current expectation and assumptions and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Corporation with respect to future events and are subject to certain
risks and uncertainties and other risks detailed from time-to-time in
the Corporation’s ongoing filings with the securities regulatory
authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual
results, events, and performance may differ materially. Readers are
cautioned not to place undue reliance on these forward-looking
statements. The Corporation undertakes no obligation to publicly update
or revise any forward- looking statements either as a result of new
information, future events or otherwise, except as required by
applicable securities laws.
Neither the TSX Venture Exchange, its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture
Exchange) nor the OTCQB accepts responsibility for the adequacy or
accuracy of this press release.
Posted by AGORACOM-JC
at 3:56 PM on Monday, December 17th, 2018
Pursuant to the Plan of Arrangement and the Arrangement with Beauce Gold Fields Inc. (BGF)
HPQ declares the special dividends stemming therefrom and that December 24, 2018 will be the Record Date for the distribution and the dividends consist of 10,680,000 Beauce Gold Fields common shares.
MONTREAL, Dec. 17, 2018 — HPQ Silicon Resources Inc (“HPQâ€) (TSX Venture: HPQ) is pleased to inform shareholders that, pursuant to the Plan of Arrangement and the Arrangement with Beauce Gold Fields Inc. (BGF), HPQ declares the special dividends stemming therefrom and that December 24, 2018 will be the Record Date for the distribution and the dividends consist of 10,680,000 Beauce Gold Fields common shares.
Only shareholders of record as at the share distribution record date
will be entitled to receive the share dividends. Shareholders of record
on that date will receive one share of BGF, for 0.0480466 shares they
own of HPQ, the dividend per share ratio is subject to adjustment based
on the number of shares of HPQ to be issued until the record date.
December 31, 2018 would be the expected payment date. Fractional shares
of BGF will be rounded down to the nearest whole number. Shareholders
who sell their HPQ shares prior to the share distribution record date
will not be entitled to receive shares of BGF. BGF confirms the
definitive and unconditional closing of the plan of arrangement and BGF
Private Placement of $550,000 announced on December 12, 2018.
Distribution Details:
Accordingly, HPQ will distribute 10,680,000 BGF shares to
it’s shareholders on a pro rata basis of 0.0480466 shares for every HPQ
shares they own hold as of close of business on the record date.
Issuer Name:
HPQ-Silicon Resources Inc.
Declaration Date:
December 17, 2018
Security Symbol
TSX-Venture Exchange: HPQ
Type of Security:
Common Shares
Type of Dividend:
Special Dividend distribution of BGF Shares
Record Date:
December 24, 2018
Ex-Distribution Date:
December 21, 2018
Payable Date:
December 31, 2018
The Company will announce the Listing Date of BGF shares on the
Venture Exchange as soon as it receives confirmation form the Exchange.
About Beauce Gold Fields
BGF is a wholly owned subsidiary of HPQ Silicon into which HPQ gold
assets were transferred. Subject to approval by TSX-V, HPQ is in the
process of listing BGF as a new public junior gold company., following
the approval by shareholders during HPQ AGM held on Aug. 10, 2018, of
the proposed terms of the plan of arrangement.
The Beauce Gold Fields project is a unique, historically prolific
gold property located in the municipality of Saint-Simon-les-Mines in
the Beauce region of Southern Quebec. Comprising of a block of 152
claims 100% owned by HPQ, the project area hosts a six kilometre long
unconsolidated gold-bearing sedimentary unit (a lower saprolite and an
upper brown diamictite). Textural observations (angularity) of gold
nuggets suggest a relatively proximal source and therefore a short
transport distance. The gold in saprolite indicates a close proximity to
a bedrock source of gold, providing possible further exploration
discoveries. The property was also hosts numerous historical gold mines
that were active from 1860s to the 1960s (see HPQ SEDAR-filed report).
HPQ Silicon Resources Inc. is a TSX-V listed resource company
planning to become a vertically integrated and diversified High Purity,
Solar Grade Silicon Metal (SoG Si) producer and a manufacturer of multi
and monocrystalline solar cells of the P and N types, required for
production of high performance photovoltaic conversion.
HPQ’s goal is to develop, in collaboration with industry leaders,
PyroGenesis (TSX-V: PYR) and Apollon Solar, that are experts in their
fields of interest, the innovative PUREVAPTM “Quartz Reduction Reactors
(QRR)â€, a truly 2.0 Carbothermic process (patent pending), which will
permit the transformation and purification of quartz (SiO2) into high
purity silicon metal (Si) in one step and reduce by a factor of at least
two-thirds (2/3) the costs associated with the transformation of quartz
(SiO2) into SoG Si. The pilot plant equipment that will validate the
commercial potential of the process is on schedule to start mid-2019.
Disclaimers:
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward-looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Company’s current expectation and assumptions, and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Company with respect to future events and are subject to certain risks
and uncertainties and other risks detailed from time-to-time in the
Company’s on-going filings with the securities regulatory authorities,
which filings can be found at www.sedar.com. Actual
results, events, and performance may differ materially. Readers are
cautioned not to place undue reliance on these forward-looking
statements. The Company undertakes no obligation to publicly update or
revise any forward-looking statements either as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For further information contact
Bernard J. Tourillon, Chairman, President and CEO HPQ Tel (514) 907-1011 Patrick Levasseur, COO HPQ, President and CEO BGF Tel: (514) 262-9239 www.HPQSilicon.com
Posted by AGORACOM-JC
at 12:48 PM on Monday, December 17th, 2018
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
Two months after the legalization of recreational cannabis, is
the new legislation meeting its objectives? CTVNews.ca takes a look at
some of the Cannabis Act’s key goals.
Two months after recreational cannabis was legalized, Canada’s new
pot regime is still working out kinks in the supply chain and the
enforcement of new rules.
Before the cannabis legislation came into force, the federal
government listed its key objectives for the historic shift. Those goals
include keeping cannabis “out of the hands of children and youth,â€
curbing illegal marijuana sales, and ensuring a safe supply of quality
pot across the country.
More than 60 days after the first legal cannabis sales were made on
Oct. 17, are those objectives being met? CTVNews.ca takes a look at how
reality measures up against some of the government’s main promises.
Keep cannabis away from children
The Cannabis Act
states that only adults aged 18 or older can legally purchase, possess
and grow small amounts of weed. Provinces and territories were allowed
to impose their own age restrictions, and the majority have set 19 as
the legal age.
Quebec’s new Coalition Avenir Quebec government made good on its
election campaign promise and tabled legislation that would raise the
province’s legal cannabis consumption age to 21 – the highest in Canada.
Of course, those age restrictions don’t guarantee that younger teens
and kids won’t be getting their hands on pot. It remains to be seen
whether legalization will actually reduce cannabis consumption among
minors.
Reduce number of Canadians with criminal records
One of the main pillars of the Cannabis Act is reducing the burden on
the Canadian justice system by eliminating criminal charges for simple
pot possession. But what about those who were charged or convicted of
the crime before Oct. 17, 2018?
In October, the federal government announced its intention to issue
pardons to Canadians who have criminal records for possession of 30
grams of cannabis or less.
The legislation “to make things fairerâ€
was expected to be tabled before the end of 2018, but that did not
happen before MPs wrapped things up in Ottawa for the holiday break.
When it eventually becomes law, those eligible for pardons will be able
to apply as soon as the law is in effect, with no waiting period or
application fees.
The Liberal government, however, has been criticized for not opting
to expunge the criminal records of Canadians convicted of simple
possession. An expungement would remove any record of a criminal
conviction, while a pardon seals the record but does not erase it.
Safe supply of cannabis
The federal government pledged to “establish and enforce a strict
system of production, distribution and sales†of cannabis, with a focus
on regulation of quality and safety.
But some Canadians have reported receiving mouldy cannabis.
One cannabis manufacturer, RedeCan, recalled its B.E.C. strain in November after receiving reports of mould in some products sold in Ontario and British Columbia.
Under federal regulations, cannabis producers have to keep a sample of every batch they send to market.
Eliminate illicit pot sales
This is another long-term objective of the Cannabis Act, but numerous
hiccups in the legal cannabis supply chain have done little to curb
distribution of illegal weed.
Despite numerous warnings to illegal cannabis stores – and police
raids in several cities across the country – some illicit dispensaries say they’ve been busier than ever since Oct. 17.
Some consumers told The Canadian Press they continued to get their
weed from illegal dispensaries or elsewhere because of delivery delays
like the ones that plagued the Ontario Cannabis Store (OCS) in the first
month of legalization.
The OCS attributed delays to high demand for cannabis products, but
the nationwide rotating strikes by Canada Post workers were also blamed
for slow deliveries.
The online OCS is currently the only legal outlet for recreational
cannabis in Ontario, with brick-and-mortar stores expected in 2019.
In the first few weeks of business, the office of the
Ontarioombudsman received more than 1,000 complaints about the OCS,
related to delivery delays, poor customer service and issues with
billing.
By the third week of November, the provincial government said the OCS had eliminated its backlog and deliveries were “back on track.â€
British Columbia, Alberta, Manitoba, Saskatchewan, Quebec, Nova
Scotia and New Brunswick also reported varying degrees of cannabis
shortages.
New Brunswick was forced to temporarily close more than half its stores in early November, and the Quebec Cannabis Corporation had to reduce its store opening hours due to shortages.
Access to medical cannabis
One of the government’s principal objectives in legalizing
recreational pot was to provide “access to quality-controlled cannabis
for medical purposes.â€
But medical cannabis users have complained that, since Oct. 17,
they’ve experienced persistent product shortages and shipment delays.
Users of medical cannabis can only buy products from specific
licensed producers if they want their health insurance to cover the
cost. When their preferred strain or product is not available, they
either have to go without, or pay out of pocket for products from a
recreational pot retailer.
Health Canada admitted last month
that there have been localized shortages of medical cannabis since
legalization, and said they are expected to continue for months.
Protecting public health and safety
The federal government has vowed to strengthen laws aimed at
punishing “more serious cannabis offences,†including selling and
distributing pot to children and youth, and driving under the influence
of cannabis.
Legislation known as Bill C-46
sets prohibited blood drug concentrations of THC, the main psychoactive
compound of cannabis, for drivers. It also outlines penalties for drug
offences, which range from fines to imprisonment, depending on the
severity and number of offences committed.
As a result of Bill C-46, police can now demand a sample of saliva
for roadside drug screening. However, the only device approved for
roadside drug testing in Canada has been met with criticism, with some
police forces even saying they will not be using it at all.
Critics say the Drager DrugTest 5000
doesn’t work in sub-zero temperatures, is too bulky for roadside tests
and takes too long to produce a sample. But the federal government has
defended the device, saying its approval was based on scientific
recommendations of the Drugs and Driving Committee.
Bill C-46 also amended Canada’s drunk-driving laws to allow police officers to conduct mandatory roadside alcohol breath tests without requiring a suspicion that the driver had been drinking.
With files from CTVNews.ca’s Rachel Aiello and The Canadian Press
Tags: Marijuana, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Cannabis report card: How’s the legal pot regime working for Canadians? $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 10:18 AM on Monday, December 17th, 2018
Announced today that it received a purchase order to provide specialty metal powder from a government entity, the name, origin, amount, and type of powder are not permitted to be disclosed.
This order will require PyroGenesis to produce specialty reactive metal powder using its plasma atomization expertise
The Client intends to qualify this powder for undisclosed purposes.
MONTREAL, Dec. 17, 2018 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF), a TSX Venture 50® high-tech company, (the “Company”, the “Corporation†or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that it received a purchase order to provide specialty metal powder from a government entity (the “Clientâ€), the name, origin, amount, and type of powder are not permitted to be disclosed.
This order will require PyroGenesis to produce specialty reactive metal powder using its plasma atomization expertise. The Client intends to qualify this powder for undisclosed purposes.
First delivery is expected to occur Q1 2019. It is expected that,
upon successful qualification, follow-on orders would be anticipated.
“Although small, under 1 ton, this commercial order reinforces the
fact that we are, once again, the go-to Company for an entity that has,
at its fingertips, many options. Not only does this opportunity allows
us to expand our powder offerings but it also creates a potentially high
value niche market, which, once again, highlights our competitive
advantages,†said Mr. P. Peter Pascali, President and CEO of
PyroGenesis. “This order is clearly a recognition of PyroGenesis’
strengths as an innovative plasma Company, and further underscores our
position, and value, to the Additive Manufacturing industry.â€
PyroGenesis Canada Inc., a TSX Venture 50® high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward- looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Corporation’s current expectation and assumptions and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Corporation with respect to future events and are subject to certain
risks and uncertainties and other risks detailed from time-to-time in
the Corporation’s ongoing filings with the securities regulatory
authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual
results, events, and performance may differ materially. Readers are
cautioned not to place undue reliance on these forward-looking
statements. The Corporation undertakes no obligation to publicly update
or revise any forward- looking statements either as a result of new
information, future events or otherwise, except as required by
applicable securities laws.
Neither the TSX Venture Exchange, its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
nor the OTCQB accepts responsibility for the adequacy or accuracy of
this press release.
Posted by AGORACOM-JC
at 9:40 AM on Friday, December 14th, 2018
Virginia-based connected health provider Creo Wellness, LLC (confirm the companies have committed to integrate CardioComm’s ECG monitoring service technologies and ECG devices to support the CREO physician network’s management of patients and enhance the services offered through the CREO patient engagement platform
ECG technology integration across CREO’s platform to be launched in 2019
Toronto, Ontario–(December 14, 2018) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or the “Company” or “CCS“), a leading global provider of consumer heart monitoring and electrocardiogram (“ECG“) acquisition and management software solutions, and Virginia-based connected health provider Creo Wellness, LLC (“CREO“) confirm the companies have committed to integrate CardioComm’s ECG monitoring service technologies and ECG devices to support the CREO physician network’s management of patients and enhance the services offered through the CREO patient engagement platform.
CREO developed and supports its home-based, physician-directed
patient care software platform to improve the health outcomes of its
patients. CREO selected CardioComm as a preferred ECG services solutions
provider to enhance its patient care software platform, specifically
CardioComm’s over-the-counter (“OTC“) HeartCheck™
handheld ECG devices, and its traditional ECG monitoring services, such
as Holter, resting 12 lead and 14 day event monitoring.
CREO’s platform is currently used by many employers, hospital and
physician groups who collectively manage up to 300,000 patients each
month. CREO estimates that the number of managed patients per month
using its platform will triple to 900,000 by 2020.
CardioComm will integrate its GEMS™ Mobile Smartphone app into CREO’s
existing mobile application and workflow to support the option to
record an ECG at any time. All ECG’s will be managed through
CardioComm’s cloud-based GEMS™ Flex software. All ECGs will be ready by
the Company’s SMART Monitoring ECG reading service. CREO will be
notified of any reviewed ECGs with abnormalities. The ECGs will also be
flagged for remote review by the patient’s physician based on the
severity of the abnormality found.
The partnership between CREO and CCS will bring new product offerings
to the USA market in early 2019. For CardioComm Solutions, this will
generate multiple new revenue streams resulting from the licensing of
CardioComm’s GEMS™ cloud and Smart phone app ECG management tools, the
purchase of GEMS™ compatible OTC and Rx ECG devices and a fee-for-use
based on CardioComm’s SMART Monitoring ECG reading service. CREO will
place the devices into their patient care software platform, which will
be prescribed through CREO member physicians. Use of these devices will
generate revenue through the provision of ECG readings under established
USA Current Procedural Terminology (“CPT“) codes. CREO
will manage all CPT code billings for the ECG services performed. CPT
codes are maintained by the American Medical Association to provide
information about medical services and procedures among physicians,
coders, patients, accreditation organizations and payers.
All ECGs will be managed by CardioComm’s cloud-based GEMS™ Flex
software where all ECGs will be interpreted by the Company’s SMART
Monitoring ECG reading service. CREO will be notified of any reviewed
ECGs with abnormalities which will be flagged for remote review by the
patient’s physician in accordance with the severity of the abnormality
found.
Both companies expect that at least 30% of CREO patients will require
ECG monitoring ranging from routine baseline recordings to regular
daily monitoring for prolonged periods of time. The first phase of
technology integration is expected to be completed in Q1 2019, followed
by the full launch of the ECG services across the CREO platform.
To learn more about CardioComm’s products and for further updates
regarding HeartCheck™ ECG device integrations please visit the Company’s
websites at www.cardiocommsolutions.com and www.theheartcheck.com.
About Creo Wellness, LLC
Founded in 2015, Creo Wellness, LLC is a private digital health
solutions company that offers healthcare providers a truly connected
population health platform that is integrated with their electronic
medical record. Creo’s solutions offer a hyper-personalized patient
centric approach to improved health outcomes, cost reduction and patient
engagement. See how we create change at www.creochange.com. On Facebook, Creo Wellness, LLC. On Twitter @creowellness.
CardioComm Solutions’ patented and proprietary technology is used in
products for recording, viewing, analyzing and storing
electrocardiograms for diagnosis and management of cardiac patients.
Products are sold worldwide through a combination of an external
distribution network and a North American-based sales team. CardioComm
Solutions has earned the ISO 13485:2016 certification, is HIPAA
compliant and holds clearances from the European Union (CE Mark), the
USA (FDA) and Canada (Health Canada).
This release may contain certain forward-looking statements and
forward-looking information with respect to the financial condition,
results of operations and business of CardioComm Solutions and certain
of the plans and objectives of CardioComm Solutions with respect to
these items. Such statements and information reflect management’s
current beliefs and are based on information currently available to
management. By their nature, forward-looking statements and
forward-looking information involve risk and uncertainty because they
relate to events and depend on circumstances that will occur in the
future and there are many factors that could cause actual results and
developments to differ materially from those expressed or implied by
these forward-looking statements and forward-looking information.
In evaluating these statements, readers should not place undue
reliance on forward-looking statements and forward-looking information.
The Company does not assume any obligation to update the forward-looking
statements and forward-looking information contained in this release
other than as required by applicable laws, including without limitation,
Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 8:10 AM on Wednesday, December 12th, 2018
Announced Affiliate Marketing Agreements with 14 additional esports teams as the Company continues to ramp up affiliate marketing activities in support of its launch of vie.gg, the world’s first and most transparent esports betting exchange
The addition of these 14 esports teams brings the total number of esports team affiliates to 190 since the Company’s first announcement on April 5th,
ST. MARY’S, Antigua, Dec. 12, 2018 — Esports Entertainment Group, Inc. (OTCQB:GMBL) (or the “Company”), a licensed online gambling company with a specific focus on esports wagering and 18+ gaming, is pleased to announce Affiliate Marketing Agreements with 14 additional esports teams as the Company continues to ramp up affiliate marketing activities in support of its launch of vie.gg, the world’s first and most transparent esports betting exchange.
The addition of these 14 esports teams brings the total number of
esports team affiliates to 190 since the Company’s first announcement on
April 5th, signifying widespread adoption of VIE’s favourable P2P
wagering in which an esports fan always wins, as opposed to pitting fans
against the “house†where the odds are heavily stacked against esports
fans.
To this end, the Company is pleased to announce the addition of pool
betting to VIE.gg. Pool betting is a further extension of our well
received P2P model, which allows groups of opposing fans to wager
against each other when their teams go head to head. This is especially
attractive to the fan bases of smaller esports teams and is anticipated
to be very successful in 2019.
NEWEST ESPORT TEAM AFFILIATES BRINGS PENETRATION INTO SOUTH EAST ASIAN MARKET
After significant expansion in Europe, South America and Central
America, the addition of today’s esports teams represents a significant
geographical expansion as they represent our first 11 Asian esports team
partners as follows:
• Nepal:
8
• Vietnam:
2
• Bangladesh:
1
Asia represents a significant portion of the global esports market
and the Company anticipates further penetration into Asian markets in
2019.
Grant Johnson, CEO of Esports Entertainment Group, stated, “I want to
welcome all of our new esports team partners and especially those from
Asia. The region has a huge esports fan base and we look forward to
working closely with these teams as they engage with their fans at home
and around the globe.â€
ABOUT VIE.GG
vie.gg
offers bet exchange style wagering on esports events in a licensed,
regulated and secured platform to the global esports audience, excluding
jurisdictions that prohibit online gambling. vie.gg features wagering on the following esports games:
Counter-Strike: Global Offensive (CSGO)
League of Legends
Dota 2
Call of Duty
Overwatch
PUBG
Hearthstone
StarCraft II
This press release is available on our Online Investor Relations
Community for shareholders and potential shareholders to ask questions,
receive answers and collaborate with management in a fully moderated
forum at https://agoracom.com/ir/EsportsEntertainmentGroup
Redchip investor relations Esports Entertainment Group Investor Page: http://www.gmblinfo.com
Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers bet exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds licenses to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands and the Kahnawake Gaming Commission in Canada. The Company maintains offices in Antigua, Curacao and Warsaw, Poland. Esports Entertainment common stock is listed on the OTCQB under the symbol GMBL. For more information visit www.esportsentertainmentgroup.com
FORWARD-LOOKING STATEMENTS The
information contained herein includes forward-looking statements. These
statements relate to future events or to our future financial
performance, and involve known and unknown risks, uncertainties and
other factors that may cause our actual results, levels of activity,
performance, or achievements to be materially different from any future
results, levels of activity, performance or achievements expressed or
implied by these forward-looking statements. You should not place undue
reliance on forward-looking statements since they involve known and
unknown risks, uncertainties and other factors which are, in some cases,
beyond our control and which could, and likely will, materially affect
actual results, levels of activity, performance or achievements. Any
forward-looking statement reflects our current views with respect to
future events and is subject to these and other risks, uncertainties and
assumptions relating to our operations, results of operations, growth
strategy and liquidity. We assume no obligation to publicly update or
revise these forward-looking statements for any reason, or to update the
reasons actual results could differ materially from those anticipated
in these forward-looking statements, even if new information becomes
available in the future. The safe harbor for forward-looking statements
contained in the Securities Litigation Reform Act of 1995 protects
companies from liability for their forward-looking statements if they
comply with the requirements of the Act.
Posted by AGORACOM-JC
at 4:48 PM on Tuesday, December 11th, 2018
SPONSOR: Good Life
Networks (GOOD:TSX-V) Video advertising is the future! Company’s A.I.
makes 80,000 calculations / second, targeting 750 million users to
deliver higher prices and volume. Revenue was $10,000,650 for the nine
months ended September 30th, 2018, a 142% increase from $4,133,231
reported for the six months ended September 30th, 2017. Click here for more information.
New service will operate programmatic advertising requirements for AIM’s Travel Elite clients and to advertisers requiring digital planning and buying. Authorised Investment Fund (ASX: AIY)Â
Revealed that one of its investee companies, Asian Integrated Media (AIM), is making strong headway in the US$60 billion (A$83 billion) programmatic advertising sector.Â
The new service will operate programmatic advertising requirements for AIM’s Travel Elite clients and to advertisers requiring digital planning and buying. Authorised Investment Fund (ASX: AIY) has revealed that one of its investee companies, Asian Integrated Media (AIM), is making strong headway in the US$60 billion (A$83 billion) programmatic advertising sector.Â
AIM has struck a deal with Ambient Digital Group to form a joint
venture offering its bespoke digital planning and buying to advertisers
throughout south-east Asia.
Programmatic advertising is a term used in digital marketing to
describe computer-based automated buying, selling, placement, and
optimisation of digital advertising. In contrast to traditional
advertising, programmatic ad buying involves the use of non-human
software machines to purchase digital ads.
As it stands, Authorised Investment Fund owns a 25% interest in AIM
with an option to increase its holding to 30% at any time over the next 3
years.
The company first committed to acquiring a major stake in AIM in
April this year, after identifying AIM as one of the world’s leading
media sales representation networks that could both diversify and
amplify its broader investment portfolio.
The power of AIM
AIM has an expansive team working in Hong Kong, Singapore and Beijing
with a worldwide affiliate network of sales agents in all the key
cities in Europe, Asia and the US.
The deal between AIM and Ambient, offers a variety of synergies
including geographical market reach, addressable audience and sharing
mutually beneficial technology.
AIM has confirmed the newly-created service will operate the
programmatic requirements of AIM’s Travel Elite clients and to
advertisers requiring “specialist, bespoke digital planning and buying
requirementsâ€.
The rapid growth of programmatic advertising.
Currently, Ambient Digital is one of the largest independent digital
companies in south-east Asia providing a range of marketing and media
solutions delivering the entire range of digital media products to
mobile and desktop via programmatic technology platforms.
Ambient has a turnover of around US$17 million (A$23.5 million) but
hopes the deal with AIM will provide a significant boost to its
bottom-line given the strong focus on providing next-generation
advertising capabilities to its clients.
The operation currently has over 200 digital and media experts
working in across Asia and providing campaigns on all digital devices
including PCs and mobiles.
One of its key aims is to expand what it calls its “one-stop-shop for compelling universal digital campaignsâ€.
Ambient benefit
Ambient Digital provides services to advertisers in six major South
East Asian markets with a combined reach of 580 million people in peak
growth countries such as Vietnam, the Philippines, Indonesia, Thailand,
Myanmar and Singapore.
Additionally, with over 100 connections to global demand partners,
Ambient Digital’s tie-up with AIM is expected to provide a global
marketplace for publishers. With over 4 billion monthly impressions and
200 million active internet users across 5 countries, the joint venture
with AIM is forecast to provide “a perfect union to propel revenue
opportunities and support solid capital growth,†according to AIM.
A partnership with AIM could potentially propel the company to
greater heights given that AIM is the exclusive partner of several
global airlines such as Cathay Pacific, Qantas, Singapore Airlines, and
Emirates; as well as newspaper giants Handelsblatt in Germany and Daily
Mail in the UK.
Some of its other notable partners include the Hong Kong Tourism Board, Robb Report China and Richesse.
Providing the best international sales representation for premium
media, AIM is highly selective in the titles and platforms it represents
with its key portfolio in the travel and luxury lifestyle segments.
According to AIM, by combining its industry experience, longstanding
client relationships and a strong network of sales offices ensures it
can deliver the maximum level of advertising revenue for its
multifaceted media partners.
“We have been working with the Ambient Digital Group for some months
now and to be able to provide these exceptional services to our clients
who are increasingly looking to reach elite audiences through digital
platforms we can now provide bespoke solutions,†said Peter Jeffery, CEO
and Founder of Asian Integrated Media.
“It will enable us to harness and capture the opportunities of the
programmatic advertising sector as it continues to grow from
US$60billion in revenues worldwide. It is envisaged that this joint
venture will provide a solid platform for us to drive considerable
additional revenues and build substantial and solid capital growth for
both Ambient and AIM,†said Mr Jeffery.
Posted by AGORACOM-JC
at 8:25 AM on Tuesday, December 11th, 2018
Confirms its non-exclusive supply agreement for GMP-Grade THC with U.S.-based Rhodes Technologies Inc.
The supply will be used for several drug development activities including Tetra’s cannabinoid-derived products PPP002, PPP003, and PPP004, as well as for discovery phase projects.
Quality and volume of Active Pharmaceutical Ingredients (API) ensured
ORLEANS, Ontario, Dec. 11, 2018 — Tetra Bio-Pharma Inc. (“Tetra†or “TBPâ€), (TSX VENTURE: TBP) (OTCQB: TBPMF) a leader in cannabinoid-based drug discovery and development confirms its non-exclusive supply agreement for GMP-Grade THC with U.S.-based Rhodes Technologies Inc. The supply will be used for several drug development activities including Tetra’s cannabinoid-derived products PPP002, PPP003, and PPP004, as well as for discovery phase projects.  This is additional to having a supply agreement with True North Cannabis Inc.  for CBD from hemp which was necessary to meeting the demand associated with the Genacol Corporation transaction.
“With a robust development pipeline, it is essential
for Tetra to have a reliable, API supply to support our expanding needs
and avoid product shortages,†said Dr. Guy Chamberland, CEO and CSO of
Tetra Bio-Pharma. “Our agreement with Rhodes is predicated on their long
history and expertise in the production and sale of active chemical
ingredients, particularly in the area of pain management. In terms of
CBD, our suppliers are selected based on their ability to provide us
with both quality (GMP Pharmaceutical Grade) and volume. Tetra is
always mindful of the need to have consistent supply as well as back-ups
for each of the products under development.â€
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements Some statements in
this release may contain forward-looking information. All statements,
other than of historical fact, that address activities, events or
developments that the Company believes, expects or anticipates will or
may occur in the future (including, without limitation, statements
regarding potential acquisitions and financings) are forward-looking
statements. Forward-looking statements are generally identifiable by use
of the words “may”, “will”, “should”, “continue”, “expect”,
“anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or
the negative of these words or other variations on these words or
comparable terminology. Forward-looking statements are subject to a
number of risks and uncertainties, many of which are beyond the
Company’s ability to control or predict, that may cause the actual
results of the Company to differ materially from those discussed in the
forward-looking statements. Factors that could cause actual results or
events to differ materially from current expectations include, among
other things, without limitation, the inability of the Company to obtain
sufficient financing to execute the Company’s business plan;
competition; regulation and anticipated and unanticipated costs and
delays, the success of the Company’s research and development
strategies, including the ability to obtain orphan drug status, the
applicability of the discoveries made therein, the successful and timely
completion and uncertainties related to the regulatory process, the
timing of clinical trials, the timing and outcomes of regulatory or
intellectual property decisions and other risks disclosed in the
Company’s public disclosure record on file with the relevant securities
regulatory authorities. Although the Company has attempted to identify
important factors that could cause actual results or events to differ
materially from those described in forward-looking statements, there may
be other factors that cause results or events not to be as anticipated,
estimated or intended. Readers should not place undue reliance on
forward-looking statements. The forward-looking statements included in
this news release are made as of the date of this news release and the
Company does not undertake an obligation to publicly update such
forward-looking statements to reflect new information, subsequent events
or otherwise unless required by applicable securities legislation.
For further information, please contact Tetra Bio-Pharma Inc.
Robert (Bob) Bechard
Executive Vice President, Corporate Development and Licensing
